OBJECTIVE: To investigate whether osteoporosis occurs after surgical treatment for obesity. DESIGN: A cross-sectional study of ®ve groups of subjects who had undergone surgical treatment for obesity: ®ve premenopausal women; 13 post-menopausal women; seven post-menopausal women taking oestrogen replacement (HRT); ®ve men; and six women who had undergone surgical reversal (mean time 7 y). SUBJECTS: Thirty-six Caucasian subjects who had undergone jejunoileal or pancreaticobiliary bypass surgery at St George's Hospital between 1971 and 1992. Their mean age was 50.8 y (range 32 ± 69 y) and the median time since the operation was 14.8 y (range 4 ± 23 y). MEASUREMENTS: A clinical questionnaire was used to exclude possible factors, which might in¯uence bone mineral density. A single blood sample was collected for measurement of calcium, phosphate, alkaline phosphatase, albumin, magnesium, zinc, creatinine, thyroxine, 25-hydroxy-vitamin D, sex steroids, gonadotrophins and IGF-1 and 24 h urine calcium excretion was measured. Bone mineral density (BMD) was measured in the lumbar (L2-L4) spine (LS) and femoral neck (FN) by dual energy X-ray absorptiometry (DEXA). RESULTS: There was no difference in serum calcium, alkaline phosphatase, IGF-1, 25-hydroxy-vitamin D (25-OH vitamin D), magnesium or zinc concentrations between the ®ve groups. The LS-BMD T score was lower (P`0.05) in male subjects ( 7 2.08 AE 1.04 mean 1.0 AE s.d) and post-menopausal women not taking HRT ( 7 1.21 AE 1.33) compared to the surgically reversed group (0.87 AE 2.36). The male group was most severely affected, despite normal serum testosterone concentrations. Two of the ®ve men studied, had a LS-BMD T score`7 2.5 and two had a LS-BMD T score between 7 1.0 and 7 2.5. In contrast, six of the seven post-menopausal women on HRT had an LS BMD T score b 7 1.0. There was no difference in the FN-BMD between the ®ve groups. The presence of low BMD was not related to age, duration of bypass, or degree of postoperative weight loss. Iliac crest bone biopsies in three subjects with low BMD, con®rmed the presence of osteoporosis. CONCLUSIONS: Reduced bone mineral density is a complication of jejunoileal bypass surgery.
Introduction
Small intestinal disease leads to osteoporosis by mechanisms that are not fully understood. 1 In coeliac disease, the osteoporosis improves with adherence to an appropriate exclusion diet. 2 In Crohn's disease, the situation may be complicated by the administration of oral glucocorticoids, but is not entirely steroidrelated. 3, 4 The osteoporosis seen in female patients with Crohn's disease can be prevented by sex hormone replacement therapy (HRT). 5, 6 Jejunoileal bypass surgery has been performed for morbid obesity and, more recently, for hyperlipidaemia. By the 1980s it was estimated that, worldwide, many tens of thousands of operations had been performed. 7, 8, 9 Between 1971 and 1982, 182 patients underwent jejunoileal bypass for morbid obesity at St George's Hospital. This operation was effective in achieving a signi®cant long-term weight reduction in most of the patients, but by 1990, 33% of these patients had been surgically reversed because of serious, sometimes life-threatening, complications such as malnutrition, immune complex disease, renal oxalate stones, osteomalacia and electrolyte disturbance. 10, 11 In the late 1980s, the pancreaticobiliary operation described by Scopinaro et al 12 was used in an additional 39 patients.
We have studied the bone mineral densities (BMD) of patients with long-standing jejunoileal bypass surgery and compared them with those of age-matched control subjects and patients who had undergone bypass reversal and also patients with pancreaticobiliary bypass.
Patients and methods
Seventy Caucasian patients who underwent surgery for morbid obesity between 1971 and 1992 at St George's Hospital were invited, by letter, to take part in this study. Forty patients took part and 36 completed the study. After obtaining informed consent, a clinical questionnaire was administered which enquired into the presence of factors known or suspected to in¯uence BMD. These factors included smoking, alcohol use, amount of exercise taken, drug therapy including oestrogen replacement therapy (HRT) and glucocorticoids. Weight and height were measured and the body mass index (BMI) was expressed in standard form as weight (kg) divided by height (m) 2 
.
The mean age at the time of the study was 50.8 y (range 32±69 y). The average preoperative weight was 127.6 kg (range 105±191 kg) and the mean minimum recorded postoperative weight was 62.6 kg (range 60.7± 126.7 kg). Surgery had been performed, on average 14.8 y previously (range 4±23 y). All patients had normal renal, liver and thyroid function tests. Patients were divided into ®ve groups. Five pre-menopausal women had pancreaticobiliary bypass. All the other subjects had undergone jejunoileal bypass. Of these, 13 were post-menopausal women, seven were postmenopausal women taking oestrogen (and progestagen) replacement, ®ve were men and six were women who had undergone surgical reversal ( Table 1 ). All women who had undergone reversal were postmenopausal. Eight patients were smokers; none abused alcohol. Twenty ®ve patients with intact bypass operations were taking 1a-hydroxy vitamin D(1±1.5 mcgad) and 11 were taking calcium supplements(500 mg 2±3 timesad). Women had received hormone replacement for 3± 10 y (mean 8 y). All men in the study had normal serum testosterone concentrations and none reported sexual dysfunction. One male subject had experienced fragility fractures.
Biochemistry
Plasma concentrations of calcium, phosphate, alkaline phosphatase, albumin, bilirubin and alanine transaminase were measured using Technicon methodologies (Bayer Diagnostics, Newbury, Berkshire, UK Control data were provided by the manufacturer (Lunar DPX Madison, Wisconsin) and from the local population. There is a close relationship between low BMD and fracture risk. 13 The World Health Organisation (WHO) in 1994 de®ned osteopenia at a BMD T score`7 1 but b 7 2.5 and osteoporosis at a BMD T score`7 2.5. The Z score provides an index of the relative risk of fracture compared with that of an individual of the same age.
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Bone histology
In order to exclude the diagnosis of osteomalacia, three patients with low bone density had full thickness iliac crest biopsy after double tetracycline labelling. Staining using haematoxylin and eosin was performed after decalci®cation.
Statistics
Analysis was performed using one way analysis of variance, after logarithmic transformation of the 
Results
Clinical details are given in Table 1 . Pre-menopausal women were younger, were operated on using the modi®ed Scopinaro technique and the duration of bypass was less. After reversal of the bypass, patients returned virtually to their preoperative weights (data not shown). There was no difference in serum calcium, alkaline phosphatase, IGF-1, 25-OH-vit-D, serum magnesium and serum zinc levels between the ®ve groups. All values were normal.
BMD results are shown in Table 2 . Men and postmenopausal women not treated with oestrogens had the lowest BMD at the lumbar spine and these values differed signi®cantly from those in the patients who had had their operations reversed and also from normal controls. There was no difference in the femoral neck (FN) BMD, between the ®ve groups, although the men and post-menopausal women both had mean T and Z scores that were negative. The numbers of patients with BMD T scores`1 7 7 2.5 and`7 2.5 are shown in Table 3 . Higher numbers of post-menopausal women not receiving oestrogens and men had low T scores diagnostic of osteopenia and osteoporosis. Four patients had a T score`7 2.5; two postmenopausal women and two men.
The full thickness iliac crest biopsy in three patients with low BMD excluded the presence of osteomalacia.
Discussion
Osteopenia and osteoporosis are seen as sequels to a number of small bowel diseases with widely different pathologies. It has been documented in 47% of patients with treated adult coeliac disease. 16 Conversely, coeliac disease is found in at least 3% of patients referred for osteoporosis. 17 Recent studies indicate that treatment with a gluten-free diet probably protects against bone loss and, in the early stages, is associated with a gain in BMD. 2 Low BMD has also been reported in 31±39% of patients with in¯ammatory bowel disease in cross-sectional and prospective studies. 1, 3, 5, 18 The mechanism of osteopenia in in¯am-matory bowel disease is not understood, but the results suggest that there is low bone formation, in spite of normal calcium levels and the normal levels of calcium regulating hormones. Vitamin D de®ciency is not an important contributor to osteopenia. 1 Although a number of small studies have previously indicated that osteoporosis may also occur after jejunoileal bypass, 19 ± 21 most reviewers of the literature have emphasised the clinical effects of osteomalacia and secondary hyperparathyroidism. 21 This is certainly the case for the patients in this study who have been recruited from a meticulously studied cohort followed for over 20 y. In this group, Osteoporosis and obesity surgery G Bano et al osteomalacia was unrelated to age, length of time since bypass or to post-bypass weight loss. 22 In addition, plasma 25-HO-vit-D concentrations did not correlate with the histological changes in the bone in this group of patients. The conclusion was that osteomalacia is common after jejunoileal bypass and factors other than simple vitamin D de®ciency, may contribute to its development.
We studied a small number of patients who had undergone surgery a number of years ago. From the historical information available to us, the study population appeared representative of the total group that had undergone surgical treatment for obesity. The data in the present cross-sectional study suggest that low bone mineral density may be a clinically signi®cant problem in some patients who have undergone jejunoileal bypass. The patients in the reversed group had signi®cant early clinical problems necessitating reversal and are, therefore, not strictly comparable with the other patients. However, given that the mean duration of bypass surgery was approximately 10 y, their results do suggest that the marked losses of bone seen in the non-reversed patients may be correctable. Signi®cant reductions in BMD were observed in the lumbar spine (LS) of men and postmenopausal women, the greatest changes being seen in men. The explanation for this particularly striking change seen in the men is not known. The data from the post-menopausal women indicate that sex steroid replacement prevents or reverses the osteopenia associated with jejunoileal bypass. It is important to emphasise that there was no clinical or biochemical evidence that the male patients or the premenopausal women were hypogonadal. The premenopausal women all had Scopinaro procedures rather than those pioneered by Payne and this raises the possibility that the later procedure may have subtly different effects on BMD. However, given that osteoporosis has been reported in association with a multiplicity of small bowel pathologies, this seems inherently unlikely.
The mechanism by which jejunoileal bypass causes osteopenia remains uncertain. 30 Par®tt et al 19 reported metabolic bone disease with and without osteomalacia, after intestinal bypass surgery by performing tetracycline double-labelling of iliac bone biopsy in a group of these patients. Of 21 patients, six had evidence of osteomalacia with histological features of secondary hyperparathyroidism. In 15 patients without osteomalacia, there was a 24.5% reduction in trabecular bone volume compared to the controls. Bone resorption indices were not increased at the time of biopsy. The conclusion, when the data were ®rst reported in 1978, 21 was that this signi®cant bone loss (after intestinal shunt surgery) results from the combined effects of an unsustained increase in bone resorption (osteoclast-mediated and accounting for two-thirds of the effect) and a sustained decrease in bone formation (osteoblast-mediated and accounting for one-third of the effect). After reinterpretation of some of the assumptions made in the analysis of this data, they were republished in 1991 23 with the conclusion that the main effect is due to alterations in osteoblast function.
The mechanisms by which small bowel disease affect osteoblast (and osteoclast) function have not been determined. In addition to any effects on calcium and vitamin D absorption, a gut factor has been postulated. 20,23 ± 25 Release of endotoxins, with the ability to stimulate bone resorptive capability, as a result of bacterial colonisation of the blind loop, is possible. 26 This is supported by observations of an improvement in osteopenia by antibiotic treatment in a patient with Whipple's disease. 25 Our data suggest that the mechanism is sex-steroid regulated and, in this regard, it is interesting that the small intestinal epithelial cells of a number of animals have oestrogen receptors. 27 However, it is possible that the bone saving effects of oestrogen are mediated directly at the osteoclast and osteoblast irrespective of the small bowel pathology.
Insulin-like growth factors (IGFs) may play important local roles in the regulation of osteoclast and osteoblast functions. 32 We found no correlation between circulating IGF-1 concentrations and bone density. However, lower concentrations of serum IGF-1 have been reported in post-menopausal women with established osteoporosis when compared to normal controls. 28 Information on the concentrations of modulatory proteins, such as the IGF binding proteins, is required before further speculation on the possible role of this endocrine axis in the pathophysiology of osteopenia is possible.
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Conclusion
Osteoporosis is a complication of jejunoileal bypass surgery. It is not related to the age of the patient, duration of bypass and postoperative weight loss. Men overall showed striking loss of bone in comparison with the women. The reason for this ®nding remains unknown, suggesting that there are yet unidenti®ed mechanisms for skeletal abnormalities in the presence of gastrointestinal malfunction. Women receiving oestrogen and progestagen HRT and patients in whom the bypass operation has been reversed, have normal bone mineral densities. Premenopausal women undergoing biliopancreatic rather than jejunoileal bypass surgery also have normal bone densities. Until the cause of bone loss in these patients is fully understood the correct treatment remains speculative.
